Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes

被引：0
|
作者：
Ulf Hannelius
Craig A. Beam
Johnny Ludvigsson
机构：
[1] Diamyd Medical AB,Department of Biomedical Sciences
[2] Western Michigan University Homer Stryker M.D. School of Medicine,Division of Pediatrics, Department of Biomedical and Clinical Sciences (BKV), Medical Faculty
[3] Crown Princess Victoria Children’s Hospital,undefined
[4] Linköping University,undefined
来源：
Diabetologia | 2020年 / 63卷
关键词：
Antigen-specific; Autoimmune diabetes; C-peptide; GAD; Glutamic acid decarboxylase; HLA; Immunotherapy; Type 1 diabetes; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2177 / 2181
页数：4
相关论文
共 49 条
  • [21] Autoantibodies and HLA class II DR-DQ genotypes in Ugandan children and adolescents with type 1 diabetes mellitus
    Bahendeka, Silver
    Wesonga, Ronald
    Were, Thereza Piloya
    Nyangabyaki, Catherine
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2019, 39 (01) : 39 - 46
  • [22] MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ
    Van Autreve, Jan E.
    Koeleman, Bobby P. C.
    Quartier, Erik
    Aminkeng, Folefac
    Weets, Ilse
    Gorus, Frans K.
    Van der Auwera, Bart J. R.
    HUMAN IMMUNOLOGY, 2006, 67 (1-2) : 94 - 101
  • [23] HLA-DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients
    Chuzho, Neihenuo
    Mishra, Neetu
    Tandon, Nikhil
    Kanga, Uma
    Mishra, Gunja
    Sharma, Akanksha
    Mehra, Narinder K. K.
    Kumar, Neeraj
    JOURNAL OF DIABETES, 2023, : 607 - 621
  • [24] A 1-year pilot study of intralymphatic injections of GAD-alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes
    Hals, Ingrid K.
    Balasuriya, Chandima
    Casas, Rosaura
    Ludvigsson, Johnny
    Bjorklund, Anneli
    Grill, Valdemar
    DIABETES OBESITY & METABOLISM, 2023, 25 (11) : 3400 - 3409
  • [25] The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype
    Reinauer, Christina
    Rosenbauer, Joachim
    Baechle, Christina
    Herder, Christian
    Roden, Michael
    Ellard, Sian
    De Franco, Elisa
    Karges, Beate
    Holl, Reinhard W.
    Enczmann, Juergen
    Meissner, Thomas
    GENES, 2017, 8 (05) : 2 - 17
  • [26] Epitopes recognized by CBV4 responding T cells:: effect of type 1 diabetes and associated HLA-DR-DQ haplotypes
    Marttila, J
    Hyöty, H
    Näntö-Salonen, K
    Simell, O
    Ilonen, J
    VIROLOGY, 2004, 319 (01) : 27 - 35
  • [27] GAD vaccine reduces insulin loss in recently diagnosed type 1 diabetes: findings from a Bayesian meta-analysis
    Craig A. Beam
    Colleen MacCallum
    Kevan C. Herold
    Diane K. Wherrett
    Jerry Palmer
    Johnny Ludvigsson
    Diabetologia, 2017, 60 : 43 - 49
  • [28] Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)
    Rosaura Casas
    Fabrícia Dietrich
    Sara Puente-Marin
    Hugo Barcenilla
    Beatriz Tavira
    Jeannette Wahlberg
    Peter Achenbach
    Johnny Ludvigsson
    Acta Diabetologica, 2022, 59 : 687 - 696
  • [29] Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)
    Casas, Rosaura
    Dietrich, Fabricia
    Puente-Marin, Sara
    Barcenilla, Hugo
    Tavira, Beatriz
    Wahlberg, Jeannette
    Achenbach, Peter
    Ludvigsson, Johnny
    ACTA DIABETOLOGICA, 2022, 59 (05) : 687 - 696
  • [30] Tumor necrosis factor associated susceptibility to type 1 diabetes is caused by linkage disequilibrium with HLA-DR3 haplotypes
    Kumar, Neeraj
    Kaur, Gurvinder
    Tandon, Nikhil
    Mehra, Narinder
    HUMAN IMMUNOLOGY, 2012, 73 (05) : 566 - 573
12345